Decreased expression of the carboxyl terminus of heat shock cognate 70 interacting protein in human gastric cancer and its clinical significance

Gan,Lei; Liu,Dong-Bo; Lu,Hai-Feng; Long,Guo-Xian; Mei,Qi; Hu,Guang-Yuan; Qiu,Hong; Hu,Guo-Qing

doi:10.3892/or.2012.1957

Decreased expression of the carboxyl terminus of heat shock cognate 70 interacting protein in human gastric cancer and its clinical significance

Authors:
- Lei Gan
- Dong-Bo Liu
- Hai-Feng Lu
- Guo-Xian Long
- Qi Mei
- Guang-Yuan Hu
- Hong Qiu
- Guo-Qing Hu
View Affiliations

Affiliations: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China, Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China
Published online on: August 8, 2012 https://doi.org/10.3892/or.2012.1957
Pages: 1392-1398

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The carboxyl terminus of heat shock cognate 70 interacting protein (CHIP) is an E3 ubiquitin ligase, which can promote ubiquitylation and degradation of many tumor-related proteins. However, the expression of CHIP in human gastric cancer has not been investigated. In this study, the mRNA and protein levels of CHIP expression in 53 cases of gastric cancer and matched normal tissues were determined by quantitative real-time PCR, western blotting and immunohistochemistry. We showed that CHIP was registered from basal to middle portions of normal gastric mucosa. CHIP expression was notably decreased or lost in human gastric cancer samples compared with the matched normal non-cancer samples. The correlations between CHIP downregulation and the clinicopathological characteristics were also evaluated. The expression of CHIP was significantly lower in the gastric cancer samples compared to the matched normal samples at both mRNA and protein levels (P<0.05 and P<0.05, respectively). More importantly, the downregulation of CHIP was correlated with TNM stage (P=0.048) and lymph node metastasis (P=0.010) at the mRNA levels. In addition, the downregulation of CHIP was correlated with lymph node metastasis (P=0.021) and tumor differentiation (P=0.009) at the protein levels. Taken together, at both mRNA and protein levels, the decreased expression of CHIP was correlated with lymph node metastasis. Furthermore, our study suggests that a negative correlation exists between CHIP expression and tumor malignancy in human gastric cancer.

View Figures

View References

1	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar
2	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
3	Vogiatzi P, Vindigni C, Roviello F, Renieri A and Giordano A: Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol. 211:287–295. 2007. View Article : Google Scholar : PubMed/NCBI
4	Sasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol. 35:111–115. 2000.PubMed/NCBI
5	Lee JH, Han SU, Cho H, et al: A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene. 19:4947–4953. 2000. View Article : Google Scholar : PubMed/NCBI
6	Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW and Heiss MM: c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol. 18:2201–2209. 2000.PubMed/NCBI
7	Drebber U, Baldus SE, Nolden B, et al: The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep. 19:1477–1483. 2008.PubMed/NCBI
8	Shiao YH, Rugge M, Correa P, Lehmann HP and Scheer WD: p53 alteration in gastric precancerous lesions. Am J Pathol. 144:511–517. 1994.PubMed/NCBI
9	Ebert MP, Yu J, Hoffmann J, et al: Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol. 21:1708–1714. 2003. View Article : Google Scholar : PubMed/NCBI
10	Wen YG, Wang Q, Zhou CZ, Qiu GQ, Peng ZH and Tang HM: Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway. Oncol Rep. 24:89–95. 2010.PubMed/NCBI
11	Sakata M, Kitamura YH, Sakuraba K, et al: Methylation of HACE1 in gastric carcinoma. Anticancer Res. 29:2231–2233. 2009.PubMed/NCBI
12	Wu F, Shirahata A, Sakuraba K, et al: Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer. Anticancer Res. 31:3377–3380. 2011.PubMed/NCBI
13	Paoletti X, Oba K, Burzykowski T, et al: Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 303:1729–1737. 2010. View Article : Google Scholar : PubMed/NCBI
14	Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol. 12:354–362. 2006.
15	Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS and Rabkin CS: Age-specific trends in incidence of non-cardia gastric cancer in US adults. JAMA. 303:1723–1728. 2010. View Article : Google Scholar : PubMed/NCBI
16	Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY and Patterson C: Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol. 19:4535–4545. 1999.
17	Lamb JR, Tugendreich S and Hieter P: Tetratricopeptide repeat interactions: to TPR or not to TPR? Trends Biochem Sci. 20:257–259. 1995. View Article : Google Scholar : PubMed/NCBI
18	Murata S, Minami Y, Minami M, Chiba T and Tanaka K: CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2:1133–1138. 2001. View Article : Google Scholar : PubMed/NCBI
19	Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J and Patterson C: The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol. 3:93–96. 2001. View Article : Google Scholar : PubMed/NCBI
20	Meacham GC, Patterson C, Zhang W, Younger JM and Cyr DM: The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol. 3:100–105. 2001. View Article : Google Scholar : PubMed/NCBI
21	Kajiro M, Hirota R, Nakajima Y, et al: The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol. 11:312–319. 2009. View Article : Google Scholar : PubMed/NCBI
22	Xu T, Zhou Q, Zhou J, et al: Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis. Cancer Sci. 102:959–966. 2011. View Article : Google Scholar : PubMed/NCBI
23	Jang KW, Lee JE, Kim SY, et al: The C-terminus of Hsp70-interacting protein promotes Met receptor degradation. J Thorac Oncol. 6:679–687. 2011. View Article : Google Scholar : PubMed/NCBI
24	Lakshmanan M, Bughani U, Duraisamy S, Diwan M, Dastidar S and Ray A: Molecular targeting of E3 ligases - a therapeutic approach for cancer. Expert Opin Ther Targets. 12:855–870. 2008. View Article : Google Scholar : PubMed/NCBI
25	Zhou P, Fernandes N, Dodge IL, et al: ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem. 278:13829–13837. 2003. View Article : Google Scholar : PubMed/NCBI
26	McDonough H and Patterson C: CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones. 8:303–308. 2003. View Article : Google Scholar : PubMed/NCBI
27	Fan M, Park A and Nephew KP: CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-α. Mol Endocrinol. 19:2901–2914. 2005.PubMed/NCBI
28	Esser C, Scheffner M and Hohfeld J: The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem. 280:27443–27448. 2005. View Article : Google Scholar : PubMed/NCBI
29	McDonough H, Charles PC, Hilliard EG, et al: Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program. J Biol Chem. 284:20649–20659. 2009. View Article : Google Scholar : PubMed/NCBI
30	Huang H and Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
31	Li F, Xie P, Fan Y, et al: C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. J Biol Chem. 284:20090–20098. 2009. View Article : Google Scholar : PubMed/NCBI
32	Luo W, Zhong J, Chang R, Hu H, Pandey A and Semenza G: Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1α but not HIF-2α. J Biol Chem. 285:3651–3663. 2010.PubMed/NCBI